Front Desk: 469-391-0070

Inhalant Use Disorder: Symptoms, Risks, and Treatment Options
Introduction
Inhalant use disorder is a serious yet often overlooked condition involving the misuse of volatile substances commonly found in household products like glue, paint thinners, and aerosol sprays. When inhaled, these substances produce mind-altering effects, which can lead to addiction and severe health consequences. Recognized as a public health concern since the mid-20th century, inhalant use disorder is particularly prevalent among adolescents and young adults. While the immediate effects of inhalant use may feel euphoric, long-term misuse can result in significant physical and psychological harm. This article provides a comprehensive overview of inhalant use disorder, covering risk factors, symptoms, diagnostic tests, treatment options, and self-care strategies. Understanding the condition and its progression can help patients and their families take proactive steps toward recovery and seek appropriate medical care.
Definition of Inhalant Use Disorder
Inhalant use disorder is characterized by the repeated misuse of volatile substances, leading to addiction and various health complications. Multiple risk factors, including lifestyle, medical conditions, and genetics, contribute to its development. This article will explore the symptoms of inhalant use, diagnostic tests, medications, procedures, and home care strategies to help manage the disorder.
Description of Inhalant Use Disorder
Inhalant use disorder occurs when a person repeatedly inhales volatile substances such as solvents, aerosols, or gases to achieve a temporary “high.” These substances alter neurotransmitter activity in the brain, causing euphoria, dizziness, and hallucinations. However, the effects are short-lived, often lasting only a few minutes, leading to repeated use in a short period. Over time, this behavior can develop into a compulsive disorder, where the individual becomes dependent on inhalants to function or feel normal.
The progression of inhalant use disorder can be rapid, especially in younger individuals. Initially, a person may experiment with inhalants out of curiosity or due to peer pressure. However, repeated use can lead to tolerance, requiring larger amounts to achieve the same effect. This can escalate to addiction, where inhalant use takes priority over other aspects of life, such as school, work, or relationships. In severe cases, long-term inhalant use can cause irreversible damage to the brain, heart, liver, and kidneys.
According to the National Institute on Drug Abuse (NIDA), approximately 21.7 million Americans aged 12 or older have used inhalants at least once. The highest rates of use are seen in adolescents, with nearly 7% of 8th graders reporting inhalant use. Although the prevalence of inhalant use decreases with age, the health risks remain significant for all age groups.
Risk Factors for Developing Inhalant Use Disorder
Lifestyle Risk Factors
Certain lifestyle factors increase the likelihood of developing inhalant use disorder. Peer pressure is a significant contributor, especially among adolescents. Young people may experiment with inhalants due to curiosity or the desire to fit in. Additionally, the easy availability of inhalants plays a role in their misuse, as many are found in common household products. A lack of parental supervision can also contribute to the risk, as unsupervised teens may be more likely to engage in risky behaviors. Individuals experiencing boredom, stress, or emotional distress may turn to inhalants as a coping mechanism.
Medical Risk Factors
Individuals with certain medical conditions are at higher risk of developing inhalant use disorder. For example, those with a history of mental health disorders like depression, anxiety, or attention-deficit/hyperactivity disorder (ADHD) may be more prone to substance misuse, including inhalants. Additionally, individuals with a history of trauma, such as physical or emotional abuse, may use inhalants to escape or numb their pain. Chronic stress and untreated mental health conditions can further increase the risk of addiction. Moreover, individuals with a history of substance use disorder, including alcohol or drug addiction, may be more likely to experiment with inhalants as an alternative substance.
Genetic and Age-Related Risk Factors
Genetics also play a role in the development of inhalant use disorder. Individuals with a family history of substance use disorders may be genetically predisposed to addiction, including inhalant use disorder. Age is another significant risk factor, with adolescents being more susceptible to inhalant use. The developing brain of an adolescent is more vulnerable to the effects of substances, including inhalants, which can lead to quicker addiction and more severe long-term consequences. Adolescents are also more likely to engage in risky behaviors, such as experimenting with drugs, due to peer pressure and a desire for novelty.
Clinical Manifestations of Inhalant Use Disorder
Dizziness (70-80%)
Dizziness is a common symptom in individuals with inhalant use disorder, affecting 70-80% of patients. This sensation of lightheadedness or unsteadiness occurs because inhalants reduce oxygen flow to the brain. The chemicals in inhalants displace oxygen in the lungs, leading to hypoxia (low oxygen levels), which causes dizziness. This symptom often appears early in the disorder, especially during or immediately after inhalation. Repeated episodes of dizziness may indicate increasing dependence on inhalants.
Euphoria (60-75%)
Euphoria, an intense feeling of happiness or pleasure, is experienced by 60-75% of individuals using inhalants. This occurs because inhalants affect the brain’s reward system, releasing dopamine, a neurotransmitter associated with pleasure. The euphoria is short-lived, lasting only a few minutes, leading to repeated use to maintain the sensation. This cycle contributes to dependence and addiction. Euphoria is more common in the early stages of inhalant use but can persist as the disorder progresses.
Hallucinations (25-40%)
Hallucinations, or seeing or hearing things that aren’t there, occur in 25-40% of people with inhalant use disorder. Inhalants disrupt normal brain function, leading to altered perceptions of reality. These hallucinations may be visual, auditory, or tactile and are often short-lived but can be frightening. Hallucinations are more likely with higher doses of inhalants or in individuals who have been using inhalants for a longer period. In some cases, hallucinations may indicate more severe neurological damage.
Slurred Speech (50-65%)
Slurred speech, affecting 50-65% of individuals with inhalant use disorder, occurs when inhalants impair the central nervous system. This impairment affects the brain’s ability to coordinate the muscles involved in speech, leading to slow or unclear speech patterns. Slurred speech is often noticeable immediately after inhalant use and may persist as long as the drug is active in the body. Chronic use can lead to more persistent speech difficulties, even when not actively using inhalants.
Impaired Coordination (55-70%)
Impaired coordination, seen in 55-70% of patients, is another common symptom of inhalant use disorder. Inhalants interfere with the brain’s ability to send signals to the muscles, leading to difficulty with balance, walking, and performing fine motor tasks. This symptom is often temporary, occurring shortly after inhalant use, but repeated exposure can cause lasting damage to the cerebellum, the part of the brain responsible for coordination. Over time, individuals may experience long-term difficulties with movement and coordination.
Nausea (40-55%)
Nausea affects 40-55% of individuals using inhalants due to the body’s reaction to toxic chemicals. When inhaled, these substances can irritate the stomach lining and affect the brain’s vomiting center, leading to nausea. Nausea is more common in individuals new to inhalant use or those who use large amounts at once. Chronic users may develop a tolerance to this symptom, but it can still occur during heavy use or with certain types of inhalants.
Headaches (50-65%)
Headaches are experienced by 50-65% of individuals with inhalant use disorder. Inhalants cause blood vessels in the brain to constrict, reducing blood flow and oxygen levels, which can trigger headaches. These headaches are often described as throbbing and can last for several hours after inhalant use. Chronic users may experience more frequent and severe headaches due to ongoing damage to the brain and blood vessels.
Irritability (45-60%)
Irritability, or a tendency to become easily annoyed or angry, affects 45-60% of individuals with inhalant use disorder. This symptom results from the brain’s altered chemistry due to repeated inhalant use. Inhalants disrupt the balance of neurotransmitters, leading to mood swings and irritability. This symptom may be more pronounced during withdrawal periods as the brain struggles to regain its normal chemical balance. Over time, irritability can become a persistent issue, even when not actively using inhalants.
Mood Swings (50-70%)
Mood swings, characterized by rapid changes in emotional state, are common in 50-70% of individuals with inhalant use disorder. Inhalants affect the brain’s ability to regulate emotions, leading to sudden shifts between feelings of euphoria, anger, sadness, or anxiety. These mood swings can be unpredictable and may occur both during and after inhalant use. As the disorder progresses, mood swings may become more frequent and severe, impacting relationships and daily functioning.
Memory Problems (40-60%)
Memory problems, affecting 40-60% of individuals with inhalant use disorder, result from damage to the brain’s hippocampus, the area responsible for memory formation and retention. Inhalants can cause both short-term memory loss, such as forgetting recent events, and long-term memory issues, such as difficulty recalling past experiences. Memory problems may worsen with continued use, and in some cases, the damage can be permanent, even after stopping inhalant use.
html
Treatment Options for Inhalant Use Disorder
Medications for Inhalant Use Disorder
Naltrexone
Definition: Naltrexone blocks the effects of opioids and alcohol in the brain, helping to reduce cravings and prevent relapse in individuals with substance use disorders, including inhalant use disorder.
How and When It’s Used: Naltrexone is prescribed for individuals who have already stopped using inhalants or other substances. It can be taken orally or administered as an injection and is often part of a comprehensive treatment plan that includes counseling and behavioral therapy. It is particularly considered for those with a history of relapse or severe cravings.
Expected Outcomes: Patients may experience reduced cravings and a lower risk of relapse. Effects can be noticeable within the first few weeks, but long-term use is often recommended for sustained benefits.
Acamprosate
Definition: Acamprosate helps stabilize brain activity in individuals recovering from alcohol or substance use disorders, including inhalants, and reduces cravings and withdrawal symptoms.
How and When It’s Used: Acamprosate is prescribed after the patient has stopped using inhalants. It is taken orally, usually three times a day, and is most effective when combined with counseling and therapy. It is often used for individuals with multiple relapses or severe withdrawal symptoms.
Expected Outcomes: Patients may experience fewer cravings and a more stable mood, aiding in maintaining abstinence. Full effects may take several weeks to appear.
Disulfiram
Definition: Disulfiram creates an unpleasant reaction when alcohol is consumed, helping deter individuals from drinking. While not directly related to inhalants, it may be used when alcohol use is also a concern.
How and When It’s Used: Disulfiram is prescribed to individuals committed to abstaining from alcohol and inhalants. It is taken orally, and its effects last up to two weeks after the last dose. It works best when combined with behavioral therapies and support groups.
Expected Outcomes: Patients can expect unpleasant symptoms if they consume alcohol, reinforcing abstinence. It is most effective as part of a comprehensive treatment plan.
Topiramate
Definition: Topiramate helps reduce cravings and withdrawal symptoms in individuals with substance use disorders, including inhalant use disorder.
How and When It’s Used: Topiramate is prescribed off-label for inhalant use disorder. It is taken orally and often combined with other medications and behavioral therapies. It is particularly useful for individuals who have not responded well to other treatments.
Expected Outcomes: Patients may experience reduced cravings and improved mood stability. Effects may take several weeks to become noticeable.
Fluoxetine
Definition: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety, which often co-occur in individuals with inhalant use disorder.
How and When It’s Used: Fluoxetine is prescribed to individuals experiencing depression or anxiety alongside inhalant use disorder. It is taken orally and is part of a broader treatment plan that includes counseling and behavioral therapies.
Expected Outcomes: Patients may experience improved mood and reduced anxiety, helping them focus on recovery. Effects may take several weeks to become noticeable.
Sertraline
Definition: Sertraline is another SSRI used to treat depression, anxiety, and other mood disorders. It helps individuals with inhalant use disorder manage mental health symptoms.
How and When It’s Used: Sertraline is prescribed to individuals dealing with co-occurring mental health conditions like depression or anxiety. It is taken orally, usually once a day, and is most effective when combined with therapy and support groups.
Expected Outcomes: Patients can expect improvements in mood and anxiety levels, helping them stay focused on recovery. Full effects may take several weeks to appear.
Bupropion
Definition: Bupropion is used to treat depression and help individuals quit smoking. It may also help individuals with inhalant use disorder by reducing cravings and improving mood.
How and When It’s Used: Bupropion is prescribed to individuals struggling with depression or nicotine addiction alongside inhalant use disorder. It is taken orally and often combined with other medications and therapies.
Expected Outcomes: Patients may experience reduced cravings and improved mood, helping them stay committed to recovery. Effects may take a few weeks to become noticeable.
Gabapentin
Definition: Gabapentin treats nerve pain and seizures and may help manage withdrawal symptoms and reduce cravings in individuals with inhalant use disorder.
How and When It’s Used: Gabapentin is prescribed to individuals experiencing withdrawal symptoms or cravings during recovery from inhalant use. It is taken orally and often combined with other medications and therapies.
Expected Outcomes: Patients may experience relief from withdrawal symptoms and reduced cravings, helping them focus on recovery. Effects may take a few weeks to become noticeable.
Clonidine
Definition: Clonidine is used to treat high blood pressure but can also help reduce withdrawal symptoms in individuals recovering from substance use disorders, including inhalant use disorder.
How and When It’s Used: Clonidine is prescribed to individuals experiencing withdrawal symptoms during early recovery. It is taken orally or as a patch and is often combined with other medications and therapies.
Expected Outcomes: Patients may experience relief from withdrawal symptoms like anxiety and agitation, helping them stay committed to recovery. Effects are usually noticeable within a few days of starting treatment.
Mirtazapine
Definition: Mirtazapine is an antidepressant used to treat depression and anxiety. It may help individuals with inhalant use disorder who struggle with co-occurring mental health conditions.
How and When It’s Used: Mirtazapine is prescribed to individuals experiencing depression or anxiety alongside inhalant use disorder. It is taken orally, usually once a day, and often combined with therapy and support groups.
Expected Outcomes: Patients may see improvements in mood and anxiety levels, helping them focus on recovery. Full effects may take several weeks to appear.
Improving Inhalant Use Disorder and Seeking Medical Help
In addition to medications, several home remedies and lifestyle changes can support recovery from inhalant use disorder. These include:
- Support groups: Joining a support group provides emotional support and accountability during recovery.
- Stress management techniques: Practicing relaxation techniques like deep breathing or meditation helps manage stress and reduce the urge to use inhalants.
- Mindfulness practices: Mindfulness exercises help individuals stay present and avoid triggers that may lead to inhalant use.
- Exercise: Regular physical activity boosts mood and reduces cravings.
- Healthy diet: Eating a balanced diet improves overall well-being and supports recovery.
- Journaling: Writing about thoughts and feelings helps individuals process emotions and stay focused on recovery goals.
- Avoiding triggers: Identifying and avoiding situations or people that may trigger inhalant use is crucial for long-term recovery.
- Building a support network: Surrounding oneself with supportive friends and family provides encouragement and accountability.
- Engaging in hobbies: Finding new hobbies or revisiting old ones helps individuals stay busy and focused on positive activities.
- Seeking professional counseling: Therapy helps individuals address underlying mental health issues and develop coping strategies for long-term recovery.
Telemedicine offers a convenient way to access medical help for inhalant use disorder. Through virtual consultations, patients can receive support, medication management, and counseling from the comfort of their homes. This is especially helpful for individuals who may have difficulty attending in-person appointments due to work, family obligations, or transportation issues.
Living with Inhalant Use Disorder: Tips for Better Quality of Life
Living with inhalant use disorder can be challenging, but strategies can help improve quality of life. Here are some tips:
- Stay connected: Maintaining strong relationships with supportive friends and family provides emotional support during recovery.
- Set realistic goals: Recovery is a process, and setting achievable goals helps individuals stay motivated and focused.
- Practice self-care: Taking time for self-care—whether through exercise, relaxation, or hobbies—improves mental and physical well-being.
- Seek professional help: Therapy and counseling provide valuable tools for managing cravings, stress, and emotions.
- Stay informed: Educating oneself about inhalant use disorder and its effects helps individuals make informed decisions about recovery.
Conclusion
Inhalant use disorder is a serious condition that can have lasting effects on both physical and mental health. However, with the right treatment and support, recovery is possible. Early diagnosis and intervention are crucial for improving outcomes and preventing long-term complications.
If you or a loved one is struggling with inhalant use disorder, our primary care telemedicine practice is here to help. Through virtual consultations, we provide personalized treatment plans, medication management, and ongoing support to help you on your journey to recovery. Don’t wait—reach out today to start your path to a healthier, inhalant-free life.